Hudson Edge Investment Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,403
Closed -$239K 147
2019
Q3
$239K Hold
2,403
0.07% 141
2019
Q2
$222K Sell
2,403
-158
-6% -$15K 0.06% 132
2019
Q1
$242K Buy
+2,561
New +$224K 0.07% 130
2018
Q4
Sell
-6,877
Closed -$615K 158
2018
Q3
$615K Sell
6,877
-115
-2% -$10.2K 0.11% 88
2018
Q2
$555K Buy
6,992
+1,032
+17% +$85.7K 0.1% 104
2018
Q1
$532K Sell
5,960
-604
-9% -$58K 0.08% 86
2017
Q4
$685K Buy
6,564
+1,909
+41% +$215K 0.09% 67
2017
Q3
$679K Sell
4,655
-135
-3% -$18.4K 0.1% 67
2017
Q2
$622K Buy
4,790
+300
+7% +$36.8K 0.09% 79
2017
Q1
$559K Hold
4,490
0.07% 90
2016
Q4
$520K Sell
4,490
-25
-0.6% -$2.78K 0.07% 100
2016
Q3
$472K Hold
4,515
0.07% 100
2016
Q2
$445K Buy
4,515
+275
+6% +$28.4K 0.07% 99
2016
Q1
$424K Buy
4,240
+89
+2% +$9.16K 0.04% 151
2015
Q4
$497K Buy
4,151
+52
+1% +$6.02K 0.05% 114
2015
Q3
$443K Sell
4,099
-25
-0.6% -$3.1K 0.02% 114
2015
Q2
$477K Sell
4,124
-110
-3% -$12.6K 0.02% 119
2015
Q1
$488K Sell
4,234
-785
-16% -$93.8K 0.02% 120
2014
Q4
$561K Sell
5,019
-646
-11% -$68.1K 0.02% 116
2014
Q3
$537K Buy
5,665
+165
+3% +$14.9K 0.02% 114
2014
Q2
$472K Buy
5,500
+404
+8% +$30.7K 0.02% 114
2014
Q1
$356K Sell
5,096
-212
-4% -$16.8K 0.01% 121
2013
Q4
$448K Sell
5,308
-16
-0.3% -$1.27K 0.02% 113
2013
Q3
$410K Sell
5,324
-816
-13% -$57.2K 0.02% 114
2013
Q2
$359K Buy
+6,140
New +$369K 0.01% 118

Other funds holding CELG

Hudson Edge Investment Partners's CELG Position: Q4 2019 in Review

Hudson Edge Investment Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,403 shares — an estimated $239K sold.

Hudson Edge Investment Partners first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $685K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hudson Edge Investment Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 2,403 Celgene Corp shares in Q4 2019, an estimated $239K.
  • Hudson Edge Investment Partners first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Hudson Edge Investment Partners's Celgene Corp position peaked at $685K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hudson Edge Investment Partners's 13F filing for Q4 2019, filed 27 Jan 2020.